← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

JM Mid Cap Fund

Direct Plan · Growth Option · Mid Cap · Scheme code 150815

Fund houseJM Financial Mutual Fund
CategoryMid Cap
Plan & optionDirect · Growth Option
History3.8 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 4.118.7317.78 16.1521.22 24.81
Nifty Midcap 150
benchmark
1.724.387.82 13.0017.68 20.15
Mid Cap
category median
10.2119.8417.23 17.08

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 16.5% 0.89 1.23 0.99 5.50% -22.5% 88.12
Nifty Midcap 150
benchmark
15.7%0.71 0.97 -21.1%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 45 months this scheme and its benchmark share.

Growth of ₹100 since launch

8513718924120242026InvestVerdict

Drawdown from peak (%)

0%-8%-17%-25%20242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
136 -6.4% 12.9% 74.8% 15%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

JM Mid Cap Fund

Direct Plan · Growth Option

Allocation

By asset

Equity98.83%
Cash & Equivalents1.17%

By market cap

Concentration

Number of stocks67
Top 5 stocks16.30%
Top 10 stocks30.35%
Top 20 stocks50.35%
Largest holding3.52%
Largest sectorPharmaceuticals & Biotechnology 10.82%
Effective stocks52.3
Cash1.17%
InvestVerdict

JM Mid Cap Fund

Direct Plan · Growth Option · holdings

Top 18 holdings

#CompanySector% of fund
1 Auto Components3.52%
2 Electrical Equipment3.37%
3 Cigarettes & Tobacco Products3.28%
4 Auto Components3.09%
5 Pharmaceuticals & Biotechnology3.04%
6 Textiles & Apparels3.02%
7 Banks2.99%
8 Agricultural Food & other Products2.99%
9 Pharmaceuticals & Biotechnology2.53%
10 Industrial Products2.52%
11 Capital Markets2.40%
12 Banks2.21%
13 Chemicals & Petrochemicals2.11%
14 IT - Software2.01%
15 Cement & Cement Products1.98%
16 Capital Markets1.97%
17 Consumer Durables1.88%
18 Ferrous Metals1.84%

Sector split

Pharmaceuticals & Biotechnology — 10.8%Electrical Equipment — 9.8%Banks — 9.2%Auto Components — 8.3%Capital Markets — 7.9%Industrial Products — 5.4%IT - Software — 3.8%Industrial Manufacturing — 3.4%Cigarettes & Tobacco Products — 3.3%Other — 38.1%Pharmaceuticals & Biotech…10.8%Electrical Equipment9.8%Banks9.2%Auto Components8.3%Capital Markets7.9%Industrial Products5.4%IT - Software3.8%Industrial Manufacturing3.4%Cigarettes & Tobacco Prod…3.3%Other38.1%
Pharmaceuticals & Biotechnology10.82%
Electrical Equipment9.82%
Banks9.21%
Auto Components8.27%
Capital Markets7.89%
Industrial Products5.41%
IT - Software3.82%
Industrial Manufacturing3.44%
Cigarettes & Tobacco Products3.28%
Finance3.22%

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 29 Aug 2026.